BeStock  

Aquestive Therapeutics AQST

US equityMarket cap rank #3651Drug Manufacturers - Specialty & Generic
$3.46 −$0.25 (-6.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.52 +1.73%
Open$3.62
Prev close$3.71
Day range$3.41 – $3.65
Volume3.36M
Market cap$434.88M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.7%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+20.9%
Worst reaction-19.6%

Stock move on the day after each report

+20.0%2023/Q4-8.7%2024/Q1+0.9%2024/Q2-7.7%2024/Q3-7.5%2024/Q4-19.6%2025/Q1-2.1%2025/Q2+2.2%2025/Q3-2.5%2025/Q4+14.5%2026/Q1-4.1%2026/Q2-2.1%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q33 Nov 2026After Market±14.8%-2.06%Within range
2026/Q211 Aug 2026After Market±14.7%-4.08%Within range
2026/Q113 May 2026After Market±9.1%+14.53%Bigger than priced
2025/Q44 Mar 2026After Market±16.6%-2.52%Within range
2025/Q35 Nov 2025After Market±15.7%+2.17%Within range
2025/Q211 Aug 2025After Market±34.6%-2.07%Within range
2025/Q112 May 2025After Market±18.6%-19.65%Bigger than priced
2024/Q45 Mar 2025After Market±24.4%-7.53%Within range
2024/Q34 Nov 2024After Market±23.3%-7.67%Within range
2024/Q26 Aug 2024After Market±17.3%+0.88%Within range
2024/Q17 May 2024After Market±20.3%-8.73%Within range
2023/Q45 Mar 2024None±50.0%+20.05%Within range
2023/Q36 Nov 2023After Market±73.0%+4.91%Within range
2023/Q28 Aug 2023Pre Market±24.4%-5.37%Within range
2023/Q12 May 2023After Market±121.6%+20.86%Within range
2022/Q47 Mar 2023After Market±200.0%+0.00%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$7.56M-41.0% YoY
Operating profit-$14.47M-26.0% YoY
Net profit-$16.50M-6.8% YoY
Diluted EPS-$0.13+7.1% YoY
Free cash flow-$7.63M+40.8% YoY
Operating cash flow-$7.05M

Revenue, last 8 quarters

$11.9MDec '24$8.7MMar '25$10.0MJun '25$12.8MSep '25$13.0MDec '25$14.4MMar '26$13.8MJun '26$7.6MSep '26

Net profit, last 8 quarters

$-17.1MDec '24$-22.9MMar '25$-13.5MJun '25$-15.4MSep '25$-31.9MDec '25$-8.1MMar '26$-22.9MJun '26$-16.5MSep '26

Profitability & balance sheet

Gross margin65.3%
Operating margin-114.1%
Net margin-162.3%
Return on assets-56.0%
Current ratio6.12
Liabilities / assets159.4%
Cash & investments$90.35M
Total debt$58.15M
Net cash (debt)$32.20M

Discussion

No comments yet — be the first to weigh in on AQST.

Sign in to join the discussion.

Scroll to Top